Published in J Virol on March 01, 1992
Retracted Identification of a novel Gammaretrovirus in prostate tumors of patients homozygous for R462Q RNASEL variant. PLoS Pathog (2006) 10.08
An infectious retrovirus susceptible to an IFN antiviral pathway from human prostate tumors. Proc Natl Acad Sci U S A (2007) 4.77
Cloning of the cellular receptor for amphotropic murine retroviruses reveals homology to that for gibbon ape leukemia virus. Proc Natl Acad Sci U S A (1994) 4.67
High-titer packaging cells producing recombinant retroviruses resistant to human serum. J Virol (1995) 4.59
A human amphotropic retrovirus receptor is a second member of the gibbon ape leukemia virus receptor family. Proc Natl Acad Sci U S A (1994) 3.42
A human cell-surface receptor for xenotropic and polytropic murine leukemia viruses: possible role in G protein-coupled signal transduction. Proc Natl Acad Sci U S A (1999) 3.13
Host range and interference studies of three classes of pig endogenous retrovirus. J Virol (1998) 2.94
pH-independent murine leukemia virus ecotropic envelope-mediated cell fusion: implications for the role of the R peptide and p12E TM in viral entry. J Virol (1994) 2.87
Cloning and characterization of a cell surface receptor for xenotropic and polytropic murine leukemia viruses. Proc Natl Acad Sci U S A (1999) 2.62
Basis for receptor specificity of nonecotropic murine leukemia virus surface glycoprotein gp70SU. J Virol (1992) 2.61
Receptor-binding domain of murine leukemia virus envelope glycoproteins. J Virol (1995) 2.60
Retroviral retargeting by envelopes expressing an N-terminal binding domain. J Virol (1995) 2.36
Functional dissection of the Moloney murine leukemia virus envelope protein gp70. J Virol (1997) 2.24
Analysis of the functional and host range-determining regions of the murine ectropic and amphotropic retrovirus envelope proteins. J Virol (1993) 2.12
Identification of a subdomain in the Moloney murine leukemia virus envelope protein involved in receptor binding. J Virol (1996) 2.12
Mutational analysis of the envelope gene of Moloney murine leukemia virus. J Virol (1993) 2.08
Receptors and entry cofactors for retroviruses include single and multiple transmembrane-spanning proteins as well as newly described glycophosphatidylinositol-anchored and secreted proteins. Microbiol Mol Biol Rev (2001) 2.06
A proline-rich motif downstream of the receptor binding domain modulates conformation and fusogenicity of murine retroviral envelopes. J Virol (1998) 1.89
Murine endogenous retroviruses. Cell Mol Life Sci (2008) 1.85
Modifications in the binding domain of avian retrovirus envelope protein to redirect the host range of retroviral vectors. J Virol (1994) 1.83
Identification of a receptor-binding pocket on the envelope protein of friend murine leukemia virus. J Virol (1999) 1.75
Activation of a cell entry pathway common to type C mammalian retroviruses by soluble envelope fragments. J Virol (2000) 1.72
Functional analysis of the cytoplasmic tail of Moloney murine leukemia virus envelope protein. J Virol (1997) 1.70
A point mutation in the env gene of a murine leukemia virus induces syncytium formation and neurologic disease. J Virol (1994) 1.65
Sequences determining the pH dependence of viral entry are distinct from the host range-determining region of the murine ecotropic and amphotropic retrovirus envelope proteins. J Virol (1993) 1.58
Six host range variants of the xenotropic/polytropic gammaretroviruses define determinants for entry in the XPR1 cell surface receptor. Retrovirology (2009) 1.55
Pseudotyping of murine leukemia virus with the envelope glycoproteins of HIV generates a retroviral vector with specificity of infection for CD4-expressing cells. Proc Natl Acad Sci U S A (1997) 1.53
Structures of endogenous nonecotropic murine leukemia virus (MLV) long terminal repeats in wild mice: implication for evolution of MLVs. J Virol (1999) 1.53
Retrovirus infection: effect of time and target cell number. J Virol (1995) 1.51
The envelope glycoprotein of human endogenous retrovirus type W uses a divergent family of amino acid transporters/cell surface receptors. J Virol (2002) 1.49
Variable regions A and B in the envelope glycoproteins of feline leukemia virus subgroup B and amphotropic murine leukemia virus interact with discrete receptor domains. J Virol (1997) 1.44
In vitro binding of purified murine ecotropic retrovirus envelope surface protein to its receptor, MCAT-1. J Virol (1997) 1.41
Three distinct envelope domains, variably present in subgroup B feline leukemia virus recombinants, mediate Pit1 and Pit2 receptor recognition. J Virol (1997) 1.41
Analysis of the murine ecotropic leukemia virus receptor reveals a common biochemical determinant on diverse cell surface receptors that is essential to retrovirus entry. J Virol (1996) 1.39
An array of murine leukemia virus-related elements is transmitted and expressed in a primate recipient of retroviral gene transfer. J Virol (1996) 1.38
Modular organization of the Friend murine leukemia virus envelope protein underlies the mechanism of infection. Proc Natl Acad Sci U S A (2001) 1.37
Characterization of the proline-rich region of murine leukemia virus envelope protein. J Virol (1998) 1.37
The mouse "xenotropic" gammaretroviruses and their XPR1 receptor. Retrovirology (2010) 1.35
Analysis of the cell fusion activities of chimeric simian immunodeficiency virus-murine leukemia virus envelope proteins: inhibitory effects of the R peptide. J Virol (1996) 1.35
Identification of envelope protein residues required for the expanded host range of 10A1 murine leukemia virus. J Virol (1997) 1.34
Analysis of the murine leukemia virus R peptide: delineation of the molecular determinants which are important for its fusion inhibition activity. J Virol (1997) 1.31
A point mutation in the binding subunit of a retroviral envelope protein arrests virus entry at hemifusion. J Virol (2004) 1.30
Cell-surface receptors for retroviruses and implications for gene transfer. Proc Natl Acad Sci U S A (1996) 1.30
Receptor-binding properties of a purified fragment of the 4070A amphotropic murine leukemia virus envelope glycoprotein. J Virol (1996) 1.26
A domain of murine retrovirus surface protein gp70 mediates cell fusion, as shown in a novel SC-1 cell fusion system. J Virol (1994) 1.25
Structure and distribution of endogenous nonecotropic murine leukemia viruses in wild mice. J Virol (1998) 1.23
Proteoglycans secreted by packaging cell lines inhibit retrovirus infection. J Virol (1996) 1.21
Simian sarcoma-associated virus fails to infect Chinese hamster cells despite the presence of functional gibbon ape leukemia virus receptors. J Virol (1998) 1.21
The role of the membrane-spanning domain sequence in glycoprotein-mediated membrane fusion. Mol Biol Cell (1999) 1.19
Identification of functional regions in the human T-cell leukemia virus type I SU glycoprotein. J Virol (1994) 1.19
Establishment and characterization of molecular clones of porcine endogenous retroviruses replicating on human cells. J Virol (2000) 1.19
Receptor binding transforms the surface subunit of the mammalian C-type retrovirus envelope protein from an inhibitor to an activator of fusion. J Virol (2001) 1.19
Identification of envelope determinants of feline leukemia virus subgroup B that permit infection and gene transfer to cells expressing human Pit1 or Pit2. J Virol (2001) 1.18
Functional interactions between monomers of the retroviral envelope protein complex. J Virol (1997) 1.17
Fusion-defective gibbon ape leukemia virus vectors can be rescued by homologous but not heterologous soluble envelope proteins. J Virol (2002) 1.16
Sequence analysis of Mus dunni endogenous virus reveals a hybrid VL30/gibbon ape leukemia virus-like structure and a distinct envelope. J Virol (1998) 1.16
Specificity in receptor usage by T-cell-tropic feline leukemia viruses: implications for the in vivo tropism of immunodeficiency-inducing variants. J Virol (2001) 1.15
The hypervariable domain of the murine leukemia virus surface protein tolerates large insertions and deletions, enabling development of a retroviral particle display system. J Virol (1999) 1.14
Regional characterization of energy metabolism in the brain of normal and MPTP-intoxicated mice using new markers of glucose and phosphate transport. J Biomed Sci (2010) 1.14
Wild mouse variants of envelope genes of xenotropic/polytropic mouse gammaretroviruses and their XPR1 receptors elucidate receptor determinants of virus entry. J Virol (2007) 1.13
HTLV-1 and -2 envelope SU subdomains and critical determinants in receptor binding. Retrovirology (2004) 1.12
Identification of the receptor binding domain of the mouse mammary tumor virus envelope protein. J Virol (2003) 1.11
Human T-cell leukemia virus type 1 (HTLV-1) and HTLV-2 use different receptor complexes to enter T cells. J Virol (2006) 1.09
Second-site changes affect viability of amphotropic/ecotropic chimeric enveloped murine leukemia viruses. J Virol (2000) 1.09
Comprehensive mutational analysis of the Moloney murine leukemia virus envelope protein. J Virol (2001) 1.08
Mechanisms of avian retroviral host range extension. J Virol (2003) 1.08
Receptor co-operation in retrovirus entry: recruitment of an auxiliary entry mechanism after retargeted binding. EMBO J (1997) 1.07
Characterization of chimeras between the ecotropic Moloney murine leukemia virus and the amphotropic 4070A envelope proteins. J Virol (1996) 1.07
Selection of an avian retrovirus mutant with extended receptor usage. J Virol (1997) 1.05
Rmcf2, a xenotropic provirus in the Asian mouse species Mus castaneus, blocks infection by polytropic mouse gammaretroviruses. J Virol (2005) 1.05
Subtle mutational changes in the SU protein of a natural feline leukemia virus subgroup A isolate alter disease spectrum. J Virol (2005) 1.04
Definition of a 14-amino-acid peptide essential for the interaction between the murine leukemia virus amphotropic envelope glycoprotein and its receptor. J Virol (1998) 1.04
Structure and mechanism of a coreceptor for infection by a pathogenic feline retrovirus. J Virol (2003) 1.03
Feline leukemia virus envelope sequences that affect T-cell tropism and syncytium formation are not part of known receptor-binding domains. J Virol (2000) 1.03
Role of variable regions A and B in receptor binding domain of amphotropic murine leukemia virus envelope protein. J Virol (1998) 1.02
A comprehensive approach to mapping the interacting surfaces of murine amphotropic and feline subgroup B leukemia viruses with their cell surface receptors. J Virol (2000) 1.01
Receptor-mediated Moloney murine leukemia virus entry can occur independently of the clathrin-coated-pit-mediated endocytic pathway. J Virol (1999) 1.01
Palmitoylation of the intracytoplasmic R peptide of the transmembrane envelope protein in Moloney murine leukemia virus. J Virol (1999) 1.01
A multistep process of leukemogenesis in Moloney murine leukemia virus-infected mice that is modulated by retroviral pseudotyping and interference. J Virol (1996) 0.99
Use of different but overlapping determinants in a retrovirus receptor accounts for non-reciprocal interference between xenotropic and polytropic murine leukemia viruses. Retrovirology (2005) 0.98
Selection of functional human antibodies from retroviral display libraries. Nucleic Acids Res (2005) 0.97
A hydrophobic patch in ecotropic murine leukemia virus envelope protein is the putative binding site for a critical tyrosine residue on the cellular receptor. J Virol (1999) 0.97
Two separate envelope regions influence induction of brain disease by a polytropic murine retrovirus (FMCF98). J Virol (1996) 0.96
Brain infection by neuroinvasive but avirulent murine oncornaviruses. J Virol (2000) 0.94
Single amino acid insertion in loop 4 confers amphotropic murine leukemia virus receptor function upon murine Pit1. J Virol (1998) 0.94
Identification of a retroviral receptor used by an envelope protein derived by peptide library screening. Proc Natl Acad Sci U S A (2007) 0.91
Functional characterization of the N termini of murine leukemia virus envelope proteins. J Virol (2001) 0.91
Change of tropism of SL3-2 murine leukemia virus, using random mutational libraries. J Virol (2004) 0.90
Refrex-1, a soluble restriction factor against feline endogenous and exogenous retroviruses. J Virol (2013) 0.89
Efficient cell infection by Moloney murine leukemia virus-derived particles requires minimal amounts of envelope glycoprotein. J Virol (2000) 0.88
Homomeric interactions between transmembrane proteins of Moloney murine leukemia virus. J Virol (1996) 0.87
Viral determinants of FeLV infection and pathogenesis: lessons learned from analysis of a natural cohort. Viruses (2011) 0.87
Mus cervicolor murine leukemia virus isolate M813 belongs to a unique receptor interference group. J Virol (2001) 0.87
Origins of the endogenous and infectious laboratory mouse gammaretroviruses. Viruses (2014) 0.85
In vivo interactions of ecotropic and polytropic murine leukemia viruses in mixed retrovirus infections. J Virol (2006) 0.84
Recombination between feline exogenous and endogenous retroviral sequences generates tropism for cerebral endothelial cells. Am J Pathol (1994) 0.84
Nucleotide sequence of Moloney murine leukaemia virus. Nature (1981) 24.82
Use of a recombinant retrovirus to study post-implantation cell lineage in mouse embryos. EMBO J (1986) 11.41
Safe and efficient generation of recombinant retroviruses with amphotropic and ecotropic host ranges. Proc Natl Acad Sci U S A (1988) 9.35
Naturally occurring murine leukemia viruses in wild mice: characterization of a new "amphotropic" class. J Virol (1976) 9.33
Lineage analysis in the vertebrate nervous system by retrovirus-mediated gene transfer. Proc Natl Acad Sci U S A (1987) 7.91
A putative murine ecotropic retrovirus receptor gene encodes a multiple membrane-spanning protein and confers susceptibility to virus infection. Cell (1989) 7.64
Characterization of a human gene conferring sensitivity to infection by gibbon ape leukemia virus. Cell Growth Differ (1990) 4.50
Retrovirus envelope glycoproteins. Curr Top Microbiol Immunol (1990) 4.22
Interference grouping of murine leukemia viruses: a distinct receptor for the MCF-recombinant viruses in mouse cells. Virology (1982) 3.86
Determinants for receptor interaction and cell killing on the avian retrovirus glycoprotein gp85. Cell (1986) 3.80
Sequence analysis of amphotropic and 10A1 murine leukemia viruses: close relationship to mink cell focus-inducing viruses. J Virol (1990) 3.77
The four classes of endogenous murine leukemia virus: structural relationships and potential for recombination. J Virol (1987) 3.57
Analysis of the env gene of a molecularly cloned and biologically active Moloney mink cell focus-forming proviral DNA. J Virol (1982) 3.40
Molecular analysis of the envelope gene and long terminal repeat of Friend mink cell focus-inducing virus: implications for the functions of these sequences. J Virol (1984) 3.09
Oligomeric structure of a prototype retrovirus glycoprotein. Proc Natl Acad Sci U S A (1988) 3.06
Envelope and long terminal repeat sequences of a cloned infectious NZB xenotropic murine leukemia virus. J Virol (1985) 3.06
An amino-terminal fragment of the Friend murine leukemia virus envelope glycoprotein binds the ecotropic receptor. J Virol (1991) 3.04
Powerful and versatile enhancer-promoter unit for mammalian expression vectors. Gene (1986) 3.01
Membrane receptors for murine leukemia viruses: characterization using the purified viral envelope glycoprotein, gp71. Cell (1976) 2.93
Different recombinant murine leukemia viruses use different cell surface receptors. Virology (1984) 2.85
Strong sequence conservation among horizontally transmissible, minimally pathogenic feline leukemia viruses. J Virol (1988) 2.62
Virological events leading to spontaneous AKR thymomas. J Virol (1991) 2.45
Different murine cell lines manifest unique patterns of interference to superinfection by murine leukemia viruses. Virology (1985) 2.44
Nucleotide sequence of the envelope gene of Gardner-Arnstein feline leukemia virus B reveals unique sequence homologies with a murine mink cell focus-forming virus. J Virol (1983) 2.24
Genetic organization of gibbon ape leukemia virus. Virology (1989) 2.18
Nucleotide sequence of the gp70 gene of murine retrovirus MCF 247. J Virol (1983) 2.13
Envelope gene and long terminal repeat determine the different biological properties of Rauscher, Friend, and Moloney mink cell focus-inducing viruses. J Virol (1985) 2.08
Susceptibility of wild mouse cells to exogenous infection with xenotropic leukemia viruses: control by a single dominant locus on chromosome 1. J Virol (1985) 1.95
Structural studies of retroviruses: characterization of oligomeric complexes of murine and feline leukemia virus envelope and core components formed upon cross-linking. J Virol (1979) 1.90
A microtransfection method using the luciferase-encoding reporter gene for the assay of human immunodeficiency virus LTR promoter activity. Gene (1990) 1.90
Structural domains of endogenous murine leukemia virus gp70s containing specific antigenic determinants defined by monoclonal antibodies. Virology (1982) 1.88
Mechanisms of enveloped virus entry into cells. Mol Biol Med (1990) 1.87
Molecular analysis and pathogenesis of the feline aplastic anemia retrovirus, feline leukemia virus C-Sarma. J Virol (1986) 1.84
Host range of mink cell focus-inducing viruses. Virology (1985) 1.65
Pathogenic and host range determinants of the feline aplastic anemia retrovirus. Proc Natl Acad Sci U S A (1988) 1.45
gp160, the envelope glycoprotein of human immunodeficiency virus type 1, is a dimer of 125-kilodalton subunits stabilized through interactions between their gp41 domains. J Virol (1991) 1.45
Topography of murine leukemia virus envelope proteins: characterization of transmembrane components. J Virol (1983) 1.45
Construction of recombinants between molecular clones of murine retrovirus MCF 247 and Akv: determinant of an in vitro host range property that maps in the long terminal repeat. J Virol (1985) 1.33
Role of a membrane glycoprotein in Friend virus-induced erythroleukemia: studies of mutant and revertant viruses. Virology (1985) 1.25
[Comparison of several protein sequences by recognition of conserved regions]. C R Acad Sci III (1986) 1.02
Specific sequences of the env gene determine the host range of two XC-negative viruses of the Rauscher virus complex. Virology (1986) 1.00
Cell surface receptors for ecotropic murine retroviruses: mobile membrane proteins that mediate binding and slow endocytosis of the viral envelope glycoprotein. Virology (1989) 0.96
Nucleotide sequence of the AIDS virus, LAV. Cell (1985) 16.81
The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1. Nature (1996) 9.25
Nucleotide sequence of the visna lentivirus: relationship to the AIDS virus. Cell (1985) 7.86
Endocytosis of major histocompatibility complex class I molecules is induced by the HIV-1 Nef protein. Nat Med (1996) 7.08
Nucleotide sequence and comparative analysis of the human papillomavirus type 18 genome. Phylogeny of papillomaviruses and repeated structure of the E6 and E7 gene products. J Mol Biol (1987) 5.13
A conserved mechanism of retrovirus restriction in mammals. Proc Natl Acad Sci U S A (2000) 4.88
Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectors. Nat Genet (1997) 4.72
Human papillomavirus 1a complete DNA sequence: a novel type of genome organization among papovaviridae. EMBO J (1982) 4.13
Antiviral activity of the proteasome on incoming human immunodeficiency virus type 1. J Virol (1998) 3.21
Human immunodeficiency virus type 1 Nef increases the efficiency of reverse transcription in the infected cell. J Virol (1995) 3.04
An amino-terminal fragment of the Friend murine leukemia virus envelope glycoprotein binds the ecotropic receptor. J Virol (1991) 3.04
Nef interacts with the mu subunit of clathrin adaptor complexes and reveals a cryptic sorting signal in MHC I molecules. Immunity (1998) 2.95
Cytosolic Gag p24 as an index of productive entry of human immunodeficiency virus type 1. J Virol (1998) 2.82
Comparative analysis of the human type 1a and bovine type 1 papillomavirus genomes. J Virol (1983) 2.69
Human immunodeficiency virus type 1 entry into macrophages mediated by macropinocytosis. J Virol (2001) 2.67
Receptor-binding domain of murine leukemia virus envelope glycoproteins. J Virol (1995) 2.60
Intracellular trafficking of adeno-associated virus vectors: routing to the late endosomal compartment and proteasome degradation. J Virol (2001) 2.56
Determinants of rat albumin promoter tissue specificity analyzed by an improved transient expression system. Mol Cell Biol (1987) 2.52
Fine structure of the cottontail rabbit papillomavirus mRNAs expressed in the transplantable VX2 carcinoma. J Virol (1985) 2.40
Genomic structure of the cottontail rabbit (Shope) papillomavirus. Proc Natl Acad Sci U S A (1985) 2.40
Characterization of a transcriptional promoter of human papillomavirus 18 and modulation of its expression by simian virus 40 and adenovirus early antigens. J Virol (1987) 2.21
Efficient and stable adeno-associated virus-mediated transduction in the skeletal muscle of adult immunocompetent mice. Hum Gene Ther (1997) 2.09
Canine adenovirus vectors: an alternative for adenovirus-mediated gene transfer. J Virol (2000) 2.00
A putative truncated cytokine receptor gene transduced by the myeloproliferative leukemia virus immortalizes hematopoietic progenitors. Cell (1990) 1.89
Correction of lysosomal storage in the liver and spleen of MPS VII mice by implantation of genetically modified skin fibroblasts. Nat Genet (1993) 1.87
Retroviral-mediated gene transfer into hepatocytes in vivo. Proc Natl Acad Sci U S A (1991) 1.87
Regulation of diaminopimelate decarboxylase synthesis in Escherichia coli. II. Nucleotide sequence of the lysA gene and its regulatory region. J Mol Biol (1983) 1.85
Long-term control of erythropoietin secretion by doxycycline in mice transplanted with engineered primary myoblasts. Nat Med (1997) 1.83
Modifications in the binding domain of avian retrovirus envelope protein to redirect the host range of retroviral vectors. J Virol (1994) 1.83
MHC-I-restricted presentation of HIV-1 virion antigens without viral replication. Nat Med (2001) 1.81
Polyethylenimine-mediated gene delivery: a mechanistic study. J Gene Med (2001) 1.66
Molecular cloning, refined physical map and heterogeneity of methylation sites of papilloma virus type 1a DNA. Eur J Biochem (1980) 1.64
Long-term expression and repeated administration of AAV type 1, 2 and 5 vectors in skeletal muscle of immunocompetent adult mice. Gene Ther (2006) 1.61
One step screening of retroviral producer clones by real time quantitative PCR. J Gene Med (2000) 1.50
Impairment of T cell receptor-dependent stimulation in CD4+ lymphocytes after contact with membrane-bound HIV-1 envelope glycoprotein. Virology (1994) 1.50
Expression of human adenosine deaminase in mice reconstituted with retrovirus-transduced hematopoietic stem cells. Proc Natl Acad Sci U S A (1990) 1.49
Human immunodeficiency virus type 1 Nef induces accumulation of CD4 in early endosomes. J Virol (1995) 1.49
Reduced cell surface expression of processed human immunodeficiency virus type 1 envelope glycoprotein in the presence of Nef. J Virol (1993) 1.48
Structure of adeno-associated virus vector DNA following transduction of the skeletal muscle. J Virol (1999) 1.44
Distinct trafficking pathways mediate Nef-induced and clathrin-dependent major histocompatibility complex class I down-regulation. J Virol (2000) 1.44
Papillomavirus genomes: sequences and consequences. J Invest Dermatol (1984) 1.38
Production of erythropoietin-like activity by a murine erythroleukemia cell line. Proc Natl Acad Sci U S A (1983) 1.30
Lentiviral vectors targeting WASp expression to hematopoietic cells, efficiently transduce and correct cells from WAS patients. Gene Ther (2006) 1.29
Receptor-binding properties of a purified fragment of the 4070A amphotropic murine leukemia virus envelope glycoprotein. J Virol (1996) 1.26
A lentiviral vector encoding the human Wiskott-Aldrich syndrome protein corrects immune and cytoskeletal defects in WASP knockout mice. Gene Ther (2005) 1.24
Nef is required for efficient HIV-1 replication in cocultures of dendritic cells and lymphocytes. Virology (2001) 1.18
AAV-mediated delivery of a mutated myostatin propeptide ameliorates calpain 3 but not alpha-sarcoglycan deficiency. Gene Ther (2007) 1.17
Control of erythropoietin delivery by doxycycline in mice after intramuscular injection of adeno-associated vector. Blood (1998) 1.16
Viral expression in two myelomonocytic cell lines obtained from long-term bone marrow culture infected with the Friend polycythemia-inducing virus (FV-P). Virology (1982) 1.16
Canine adenovirus type 2 attachment and internalization: coxsackievirus-adenovirus receptor, alternative receptors, and an RGD-independent pathway. J Virol (2000) 1.16
Production of spliced DNA copies of the cottontail rabbit papillomavirus genome in a retroviral vector. Ciba Found Symp (1986) 1.14
Reversal of pathology in the entire brain of mucopolysaccharidosis type VII mice after lentivirus-mediated gene transfer. Hum Gene Ther (2000) 1.14
Human immunodeficiency virus type I Nef independently affects virion incorporation of major histocompatibility complex class I molecules and virus infectivity. Virology (1997) 1.11
Successful interference with cellular immune responses to immunogenic proteins encoded by recombinant viral vectors. J Virol (2001) 1.11
Regulatory function of in vivo anergized CD4(+) T cells. Proc Natl Acad Sci U S A (2001) 1.10
Regulation of gene expression in vivo following transduction by two separate rAAV vectors. Nat Biotechnol (1998) 1.09
Liver-directed gene transfer vectors. Hum Gene Ther (1998) 1.06
Definition of a 14-amino-acid peptide essential for the interaction between the murine leukemia virus amphotropic envelope glycoprotein and its receptor. J Virol (1998) 1.04
Activation pathways and human immunodeficiency virus type 1 replication are not altered in CD4+ T cells expressing the nef protein. AIDS Res Hum Retroviruses (1992) 1.04
Factors influencing cross-presentation of non-self antigens expressed from recombinant adeno-associated virus vectors. J Gene Med (2001) 1.02
Long-term and significant correction of brain lesions in adult mucopolysaccharidosis type VII mice using recombinant AAV vectors. Mol Ther (2000) 1.02
Disappearance of lysosomal storage in spleen and liver of mucopolysaccharidosis VII mice after transplantation of genetically modified bone marrow cells. Blood (1993) 1.01
Complete atherosclerosis regression after human ApoE gene transfer in ApoE-deficient/nude mice. Arterioscler Thromb Vasc Biol (2000) 1.01
Noninvasive monitoring of therapeutic gene transfer in animal models of muscular dystrophies. Gene Ther (2006) 1.00
Production and neurotropism of lentivirus vectors pseudotyped with lyssavirus envelope glycoproteins. Mol Ther (2001) 1.00
Modulation of phosphate uptake and amphotropic murine leukemia virus entry by posttranslational modifications of PIT-2. J Virol (1999) 0.99
Opposite effects of SDF-1 on human immunodeficiency virus type 1 replication. J Virol (1999) 0.98
Transmembrane topology of PiT-2, a phosphate transporter-retrovirus receptor. J Virol (2001) 0.96
Retroviral vectors for the transduction of the PML-RARalpha fusion product of acute promyelocytic leukemia. Exp Hematol (1996) 0.96
Use of specific single stranded DNA probes cloned in M13 to study the RNA synthesis of four temperature-sensitive mutants of HK/68 influenza virus. Nucleic Acids Res (1982) 0.96
Retroviral-mediated gene transfer corrects very-long-chain fatty acid metabolism in adrenoleukodystrophy fibroblasts. Proc Natl Acad Sci U S A (1995) 0.95
Multistep virus-induced leukemogenesis in vitro: description of a model specifying three steps within the myeloblastic malignant process. Mol Cell Biol (1984) 0.94
Design of a polyepitope construct for the induction of HLA-A0201-restricted HIV 1-specific CTL responses using HLA-A*0201 transgenic, H-2 class I KO mice. Eur J Immunol (2001) 0.93
Role of N-linked glycosylation in the activity of the Friend murine leukemia virus SU protein receptor-binding domain. Virology (1994) 0.93
Comparison of different bioreactor systems for the production of high titer retroviral vectors. Biotechnol Prog (2001) 0.93
High throughput production, screening and analysis of adeno-associated viral vectors. Gene Ther (2000) 0.93
Long-term secretion of therapeutic proteins from genetically modified skeletal muscles. Hum Gene Ther (1996) 0.93
Efficient DNA transfection mediated by the C-terminal domain of human immunodeficiency virus type 1 viral protein R. J Virol (2000) 0.93
HLA-A*0201-restricted cytolytic responses to the rtTA transactivator dominant and cryptic epitopes compromise transgene expression induced by the tetracycline on system. Mol Ther (2004) 0.92
Autocrine function of murine F-MuLV induced myeloblastic cell lines. Int J Cancer (1983) 0.92
Adeno-associated virus pseudotype 5 vector improves gene transfer in arthritic joints. Hum Gene Ther (2005) 0.91
Control of erythropoietin secretion by doxycycline or mifepristone in mice bearing polymer-encapsulated engineered cells. Hum Gene Ther (1999) 0.91
In vivo gene transfer by intravenous administration of stable cationic lipid/DNA complex. Pharm Res (1997) 0.91
Malignant myeloblastic transformation of murine long-term bone marrow cultures by F-MuLV: in vitro reproduction of a long-term leukemogenesis, and investigation of preleukemic events. Int J Cancer (1983) 0.89
Improvement of erythropoiesis in beta-thalassemic mice by continuous erythropoietin delivery from muscle. Blood (2000) 0.89